Your Article Summary
See Latest ArticlesCandesartan: widening indications for this angiotensin II receptor blocker
Expert Opinion in Pharmacotherapy, 07/01/09
Mendis B et al. - Its use has increased dramatically, with recently published data suggesting benefit in the treatment of stroke, heart failure, diabetic renal disease and most recently in preventing the development of or delaying the progression of diabetic retinopathy. In this article authors review the literature on the use of ARB drugs in general before focusing on candesartan.
Today in Basic Science...keeping you current
Receive free subspecialty "5-minute updates" via email
UGT1A10: Activity against the tobacco-specific nitrosamine, NNAL, and a potential role for a novel UGT1A10 promoter deletion polymorphism in cancer susceptibility
Drug Metabolism and Disposition, 12/14/09
Glucuronidation of Psilocin and 4-Hydroxyindole by the Human UDP-glucuronosyltransferases
Drug Metabolism and Disposition, 12/14/09
Glucuronidation of Dihydrotestosterone and Trans-androsterone by Recombinant UGT1A4: Evidence for Multiple UGT1A4 Aglycone Binding Sites
Drug Metabolism and Disposition, 12/14/09